Search Results
Angiotensin Converting Enzyme Inhibitor Peptide 5 mg | ≥95%
LKT Laboratories, Inc.
Angiotensin, dog/rat 25 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derivative of AT I, cleavage product of angiotensin, precursor to AT II.
More Information Supplier PageAngiotensin, dog/rat 10 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derivative of AT I, cleavage product of angiotensin, precursor to AT II.
More Information Supplier PageAngiotensin, dog/rat 5 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derivative of AT I, cleavage product of angiotensin, precursor to AT II.
More Information Supplier PageAmyloid-β (25-35) 2 mg | ≥95%
LKT Laboratories, Inc.
Endogenous APP peptide cleavage product, primary component in amyloid plaques typical of Alzheimer’s disease.
More Information Supplier PageAmyloid-β (25-35) 1 mg | ≥95%
LKT Laboratories, Inc.
Endogenous APP peptide cleavage product, primary component in amyloid plaques typical of Alzheimer’s disease.
More Information Supplier PageAmylin, human 2.5 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide hormone inolved in gastric emptying, gastric acid secretion, enteric contraction; calcitonin-RAMP agonist.
More Information Supplier PageAmylin, human 1 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide hormone inolved in gastric emptying, gastric acid secretion, enteric contraction; calcitonin-RAMP agonist.
More Information Supplier PageAmylin, human 0.5 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide hormone inolved in gastric emptying, gastric acid secretion, enteric contraction; calcitonin-RAMP agonist.
More Information Supplier Page